1

MEDICAL PUBLICATION
CONFERENCES AND SEMINARS
MARKETING RESEARCH

  • Complex approaches to curing teenage deficiencies of iron, zink and vitamins of B group 
en To content Full text of article

Complex approaches to curing teenage deficiencies of iron, zink and vitamins of B group 

SOVREMENNAYA PEDIATRIYA.2016.3(75):45-53; doi10.15574/SP.2016.75.45 

Complex approaches to curing teenage deficiencies of iron, zink and vitamins of B group 

Berezhyi V. V., Korneva V. V.

P.L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine 

This scientific review of domestic and foreign medical literature is devoted to the analysis of the problem of iron and zinc deficiencies and hypovitaminosis of B vitamins among schoolchildren. Medical and social issues of iron deficiency among children are analyzed. Authors conclude that this problem increasingly affects schoolchildren, particularly adolescents. Article provides analysis of the main clinical 'masks' of the latent iron deficiency, characterized by their relationship to other deficient syndromes, namely zinc deficiency and hypovitaminosis of B vitamins. This review focuses on the relationship of deficiency of iron, zinc, vitamins B1, B2, B6, and B9 with transient post-infectious secondary immunodeficiency conditions among the children of the school age. The problem of iron deficiency among teenage girls with hyperpolymenorrhea and the relationship of this condition with the further fertile function are given particular attention. Article contains analysis of ROTAFER PLUS — a medicine that is new to Ukrainian pharmaceutical market. This medicine contains iron (III)-hydroxide polymaltose complex of ferric iron (IPC Fe3+), zinc gluconate, vitamins В1. В6. В2 and В9. Availability of IPC Fe3+ in this dietary supplement, which is well tolerated by child's body, allows the use of this drug for several months and this is very important in the treatment of iron deficiencies, especially the latent ones, among adolescents.

Using of ROTAFER PLUS is suitable for monthly maintenance ferrotherapy aimed at preventing normal iron levels in teenage girls suffering from hyperpolymenorrhea.


Key words: iron and zinc deficiencies, ferrotherapy, children, adolescents.


REFERENCES

1. Abaturov AE. 2008. Mikroelementnyiy balans i protivoinfektsionnaya zaschita u detey. Zdorove rebenka. 1: 47—49.

2. Anemii u detey: diagnostika i lechenie. Prakticheskoe posobie dlya vrachey. Pod red A Rumyantseva, YuN Tokareva. Moskva, MAKS-Press, 2000: 492.

3. Vologzhanin DA, Kalinina NM, Knyazev PS. 2005.Immunitet i pitanie. Rossiyskiy biomeditsinskiy zhurnal. 6: 626—647.

4. Diahnostyka i profilaktyka defitsytu zaliza i zalizodefitsytnoi anemii u nemovliat i ditei pereddoshkilnoho viku. Rekomendatsii Amerykanskoi akademii pediatrii. 2010.

5. Zalizodefitsytna anemiia. Adaptovana klinichna nastanova, zasnovana na dokazakh. 2015. http://www.moz.gov.ua/docfiles/dn_20151102_0709dod_ukp.pdf/.

6. Zaharova IN, Dmitrieva YuA. 2011. Sindrom anemii v praktike pediatra: differentsialnaya diagnostika i terapiya. EF Pediatriya. 3. http://medi.ru.

7. Zubarenko OV, Huriienko KO. 2006. Metabolichna korektsiia zalizodefitsytnykh anemii u ditei. Sovremennaya pediatriya. 1(10): 110—112.

8. Kazyukova TV. 2004. Pokazateli ferrokinetiki pri infektsionno-vospalitelnyih zabolevaniyah u detey rannego vozrasta. Pediatriya. 3: 42—49.

9. Korzhynskyi YuS, Lisnyi AE. 2009. Rol tsynku v normi ta pry patolohii. Zdorovia dytyny. 1(16): 52—57.

10. Korneva VV. 2015. Mediko-sotsialnyie posledstviya defitsita zheleza u detey. Sovremennaya pediatriya. 1: 101—105.

11. Korneva VV. 2013. Optimalnyiy vyibor preparatov zheleza v lechenii zhelezodefitsitnoy anemii detey. Sovremennaya pediatriya. 4: 45—50.

12. Marushko YuV. 2013. Mikroelementy ta stan imunitetu u ditei. Aktualna infektolohiia. 1(1): 24—27.

13. Pediatriia. Natsionalnii pidruchnyk. U 2 t. Za red prof VV Berezhnoho. Kyiv, 2013. 1: 872—894.

14. Pro zatverdzhennia norm fiziolohichnykh potreb naselennia Ukrainy v osnovnykh kharchovykh rechovynakh ta enerhii. Nakaz MOZ Ukrainy №272 vid 18.11.99. http://www.moz.gov.ua.

15. Kazyukova TV, Tulupova EV, Alieva AM et al. 2012. Strategiya lecheniya zhelezodefitsitnoy anemii u detey rannego vozrasta. Pediatriya. 91; 4: 89—97.

16. Studenikin VM, Shelkovskiy VI. 2008. Vitaminno-mineralnyie kompleksyi dlya detey: instrument neyrodietologii. Pediatriya. 87; 6: 105—109.

17. Torshin IYu, Gromova OA, Hadzhidis AK. 2010. Sistematicheskiy analiz molekulyarnyih mehanizmov vozdeystviya zheleza, medi, margantsa v patogeneze zhelezodefitsitnoy anemii. Klinicheskaya farmakol. 3: 32—36.

18. Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta medychnoi dopomohy. Zalizodefitsytna anemiia. Nakaz MOZ Ukrainy №709 vid 02.11.2015. http://www.moz.gov.ua.

19. Niankovskyi SL, Dobrianskyi DO, Shadrin OH et al. 2013. Kharchovi defitsyty u ditei pershykh 3 rokiv zhyttia za danymy multytsentrovoho doslidzhennia v Ukraini. Zdorovia dytyny. 5(48): 45—52.

20. Shadrin OG, Dyukareva-Bezdenezhnyih SV. 2011. Puti povyisheniya effektivnosti lecheniya bronholegochnyih zabolevaniy u detey rannego vozrasta. Zdorovia dytyny. 1(28): 58—62.

21. Scheplyagina LA, Legonkova TI, Moiseeva TYu. 2002. Klinicheskoe znachenie defitsita tsinka dlya zdorovya detey: novyie vozmozhnosti lecheniya i profilaktiki. RMZh. 10; 6: 22—25.

22. Almache ON, Del Aguila СМ. 2005. Controlled study of two compounds of ferric polymaltose in the treatment of iron deficiency anaemia in children aged between 6 months and 2 years. Journal of the Anaemia Working Group Latin America (AWGLA). 1: 31—38.

23. FDA, Electronic Orange Book. Approved Drug Products with Therapeutic Equivalence Evaluations. 20th Edition. 2000: 62.

24. Fraker PJ, King LE, Laakko TL. 2000. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 130: 1399—1406.

25. Ibs К-Н, Rink L. 2003. Zinc-Altered immune function. J Nutr. 133: 1452—1456.

26. Iron Deficiency Anaemia: Assessment, Prevention, and Control. A guide for programme managers. WHO; Geneva, 2001. WHO/NHD/01.3.

27. King LE, Osati-Ashtiani F, Fraker PJ. 2002. Apoptosis plays a distinct role in the loss of precursor lymphocytes du ring zinc deficiency in mice. J Nutr. 132: 974—979.

28. Lukacik M, Thomas RL, Aranda JV. 2008. A Meta-analysis of the Effects of Oral Zinc in the Treatment of Acute and Persistent Diarrhea. Pediatrics. 121(2): 326—360.

29. Mocchegiani E, Muzzioli М. 2000. Therapeutic applicati of zinc in human immunodeficiency virus against opportunistic infections. J Nutr. 130: 1424—1431.

30. Prasad AS. 2000. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis. 182; Suppl 1: 62—68.

31. Recommendations to prevent and control iron deficiency with of the International Nutritional Anemia Consultative Group (INACG), WHO and UNICEF. Geneve, 2004: 82.

32. Yasa B, Agaoglu L, Unuvar Е. 2011. Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: a randomized trial in pediatric patients with iron deficiency anemia. Int J Pediatrics. 5: 2452—2456.